{
  "docId": "019de511-96cd-7638-a1d6-3e4d5ad533a5",
  "docSlug": "302359bc76c31f98badc01a5486f3d4f",
  "documentTitle": "Thorne HealthTech | IPO Presentation Deck | 45 slides",
  "authorId": "thorne-healthtech",
  "authorName": "Thorne HealthTech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7910448,
  "pageNumber": 30,
  "pageCount": 45,
  "prevPage": 29,
  "nextPage": 31,
  "slideType": "other",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide highlights a specific acquisition (DrawBridge Health) and its product (OneDraw) as a case study for their M&A strategy.",
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de511-96cd-7638-a1d6-3e4d5ad533a5/30",
  "deckHref": "/decks/019de511-96cd-7638-a1d6-3e4d5ad533a5",
  "deckJsonHref": "/decks/019de511-96cd-7638-a1d6-3e4d5ad533a5.json",
  "deckAnchorHref": "/decks/019de511-96cd-7638-a1d6-3e4d5ad533a5#slide-30",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.48,
        "y": 0.25
      },
      "kind": "image",
      "text": "OneDraw device images",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2bca6452-ffa6-4e7e-99ec-b0f7d79d1cfb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.52,
        "y": 0.85
      },
      "kind": "paragraph",
      "text": "Seamless Blood Sampling – Draws, Collects & Stabilizes",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b81e5489-6add-46d2-b556-7c480bd89e21",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "table",
      "text": "Acquisition strategy: Acquisition strategy focuses on partnering with highly-innovative companies in their early-stages and acquiring downstream after proof of concept to de-risk and capture upside potential. Targeted focus areas include: Innovative collection devices to bring healthcare to the home, Advanced technologies/AI system approaches for novel health assessment, Novel ingredients backed by clinical data. Example: Seamless blood sampling collection & stabilization, Acquired DrawBridge Health in Q2 2021, FDA 510K Cleared",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e681a6f3-c853-4bb1-b0a9-e75c1cb19cf5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Selectively Pursue Acquisitions",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b455271-267a-44eb-bde2-66cf89d4c7b1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem-Agitate-Solve (PAS)",
      "slug": "problem-agitate-solve-pas",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "ec4cd1d6-24e6-4dd8-b287-abad12fb05e9",
      "evidence": "Acquisition strategy focuses on partnering with highly-innovative companies in their early-stages and acquiring downstream after proof of concept to de-risk and capture upside potential.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 36,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "02163abf-0461-4147-884a-0d9de4f5d4ff",
      "evidence": "The deck presents the cost of inaction implicitly throughout the narrative, with an explicit mention on slide 36.",
      "position": 0,
      "objective": "What is the cost of not transforming human health?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}